Mechanism of vasoselective action of mebudipine, a new calcium channel blocker

Vascular Pharmacology

Volumn 42, Issue 1, 2004, Pages 23-29

  Mirkhani, Hossein ^a   Dirin, Mehrdad ^a   Youssef Zayeh, Iris ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Calcium channel blockers; Mebudipine; Rat aorta; Rat atrium; Vasoselectivity

Indexed keywords

CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; MEBUDIPINE; NIFEDIPINE; POTASSIUM; POTASSIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BLOOD VESSEL; CHRONOTROPISM; CONTROLLED STUDY; DEPOLARIZATION; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; DRUG SELECTIVITY; ELECTRIC POTENTIAL; INHIBITION KINETICS; INOTROPISM; MALE; MEMBRANE STEADY POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT; TIME; VASCULAR RING; VASOCONSTRICTION;

ANIMALS; AORTA, THORACIC; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CHEMISTRY, PHARMACEUTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; HEART ATRIA; HEART RATE; MALE; MEMBRANE POTENTIALS; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL CONTRACTION; NIFEDIPINE; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VASOCONSTRICTION; VASODILATION;

EID: 12344326035     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2004.12.002     Document Type: Article

References (26)

1. D.R. Abernethy, and J.B. Schwartz Calcium-antagonist drugs N. Engl. J. Med. 341 1999 1447 1457
2. S.K. Basu, C.D. Kinsey, A.J. Miller, and A. Lahiri Improved efficacy and safety of controlled-release diltiazem compared to nifedipine may be related to its negative chronotropic effect Am. J. Ther. 7 2000 17 22
3. S. Bohlooli, F. Keyhanfar, and M. Mahmoudian High performance liquid chromatography of mebudipine: application to pharmacokinetic study J. Pharm. Pharm. Sci. 4 2001 244 247
4. U. Elkayam, A. Shotan, A. Mehra, and E. Ostrzega Calcium channel blockers in heart failure J. Am. Coll. Cardiol. 22 1993 139A 144A
5. M. Faizi, M. Janahmadi, and M. Mahmoudian The effect of mebudipine and dibudipine, the two new Ca2+ channel blockers, in comparison with nifedipine on Ca2+ spikes of F1 neuronal soma membrane in Helix aspersa Acta Physiol. Hung. 90 2003 243 254
6. R. Ferrari, F. Cucchini, R. Bolognesi, T. Bachetti, A. Boraso, P. Bernocchi, G. Gaia, and O. Visioli How do calcium antagonists differ in clinical practice? Cardiovasc. Drugs Ther. 8 1994 565 575
7. C.D. Furburg, B.M. Psaty, and J.V. Meyer Nifedipine dose-related increase in mortality in patients with coronary heart disease Circulation 92 1995 1326 1331
8. T. Godfraind, C. Dessy, and S. Salomone A comparison of the potency of selective L-calcium channel blockers in human coronary and internal mammary arteries exposed to serotonin J. Pharmacol. Exp. Ther. 263 1992 112 122
9. T. Godfraind Calcium antagonists and vasodilatation Pharmacol. Ther. 64 1994 37 75
10. A.M. Gurney Mechanisms of drug-induced vasodilation J. Pharm. Pharmacol. 46 1994 242 251
11. Y. Hattori, M. Fukao, H. Houzen, F. Qi, Y. Yamada, and M. Kanno In vitro assessment for vascular selectivity of a new dihydropyridine derivative, NB-818 Eur. J. Pharmacol. 301 1996 99 106
12. K. Hermsmeyer Role of T channels in cardiovascular function Cardiology 89 Suppl. 1 1998 2 9
13. A. Hjalmarson Significance of reduction in heart rate in cardiovascular disease Clin. Cardiol. 21 Suppl. 2 1998 II3 II7
14. G.H. Hockerman, B.Z. Peterson, B.D. Johnson, and W.A. Caterall Molecular determinants of drug binding and action on L-type calcium channels Annu. Rev. Pharmacol. Toxicol. 37 1997 361 396
15. U. Jahnel, H. Nawrath, E. Carmeliet, and J. Vereecke Depolarization- induced influx of sodium in response to phenylephrine in rat atrial heart muscle J. Physiol. 432 1991 621 637
16. R. Kato, and B.N. Singh Effects of bepridil on the electrophysiologic properties of isolated canine and rabbit myocardial fibers Am. Heart J. 111 1986 271 279
17. A. Koschak, D. Reimer, I. Huber, M. Grabner, H. Glossmann, J. Engel, and J. Striessnig Alpha 1D (Cav1.3) subunits can form L-type Ca2+ channels activating at negative voltages J. Biol. Chem. 276 2001 22100 22106
18. M. Mahmoudian, H. Mirkhani, Z. Nehardani, and S. Ghiaee Synthesis and biological activity of two new calcium-channel blockers, mebudipine and dibudipine J. Pharm. Pharmacol. 49 1997 1229 1233
19. H. Mirkhani, G.R. Omrani, S. Ghiaee, and M. Mahmoudian Effects of mebudipine and dibudipine, two new calcium-channel blockers, on rat left atrium, rat blood pressure and human internal mammary artery J. Pharm. Pharmacol. 151 1999 617 622
20. S.K. Mishra, and P.I. Aaronson A role for a glibenclamide-sensitive, relatively ATP-insensitive K+ current in regulating membrane potential and current in rat aorta Cardiovasc. Res. 44 1999 429 435
21. N. Morel, and T. Godfraind Prolonged depolarization increases the pharmacological effect of dihydropyridines and their binding affinity for calcium channels of vascular smooth muscle J. Pharmacol. Exp. Ther. 243 1987 711 715
22. L.H. Opie, S. Yusuf, and W. Kübler Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies Prog. Cardiovasc. Dis. 43 2000 171 196
23. A. Schwartz Calcium antagonists: review and perspective on mechanism of action Am. J. Cardiol. 64 1989 3I 9I
24. D.J. Triggle Calcium, calcium channels, and calcium channel antagonists Can. J. Physiol. Pharm. 68 1990 1474 1481
25. A. Welling, A. Ludwig, S. Zimmer, N. Klugbauer, V. Flockerzi, and F. Hofmann Alternatively spliced IS6 segments of the alpha 1C gene determine the tissue-specific dihydropyridine sensitivity of cardiac and vascular smooth muscle L-type Ca2+ channels Circ. Res. 81 1997 526 532
26. Z. Zhang, Y. Xu, H. Song, J. Rodriguez, D. Tuteja, Y. Namkung, and H.S. Shin Functional roles of Ca(v)1.3 (alpha(1D)) calcium channel in sinoatrial nodes: insight gained using gene-targeted null mutant mice Circ. Res. 90 2002 981 987